about
Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γEffects of PPARα inhibition in head and neck paraganglioma cellsBlocking the peroxisome proliferator-activated receptor (PPAR): an overview.Anticancer Activity of Stilbene-Based Derivatives.Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies.N-acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry.Synthesis and biological evaluation of 2-heteroarylthioalkanoic acid analogues of clofibric acid as peroxisome proliferator-activated receptor alpha agonists.Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies.Selective inhibition of inducible nitric oxide synthase by derivatives of acetamidine.Discovery of gemfibrozil analogues that activate PPARα and enhance the expression of gene CPT1A involved in fatty acids catabolism.N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase.Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic cancer cell lines.Synthesis, biological evaluation, and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase.Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid.Enantiomeric separation of gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector.Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives.Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases.The Anticancer Potential of Peroxisome Proliferator-Activated Receptor Antagonists.PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells.QSAR, QSPR and QSRR in Terms of 3-D-MoRSE Descriptors for In Silico Screening of Clofibric Acid Analogues.Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitorsDiscovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular dockingThe Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In VitroSelective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidineBenzothiazole-based N-(phenylsulfonyl)amides as a novel family of PPARα antagonistsSynthesis and structure-activity relationships of fibrate-based analogues inside PPARsFibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARαStructural development studies of PPARs ligands based on tyrosine scaffoldSynthesis of Naphthyl-, Quinolin- and Anthracenyl Analogues of Clofibric Acid as PPARα AgonistsScreening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLCSynthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonistsReversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitorsDruggability profile of stilbene-derived PPAR agonists: determination of physicochemical properties and PAMPA studyDevelopment of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor
P50
Q27701568-B7A17865-6183-4AB6-8F5A-83C47921A40DQ33779008-F6B9D1AA-7933-447D-9A1A-9F9846442C9BQ38128537-B9D0C06E-AB94-4B97-B322-2222B2D5E0EDQ39165544-91318440-772D-49C4-995A-47A50A6DF662Q39249230-5C915274-7B5E-4081-93F6-691994C12A8BQ39386218-7C98D554-59CC-42AF-9DB0-EA52072A0A91Q39793388-E1E043EA-CB14-4E5A-B04D-12F0B15B2BF0Q41864145-E4067B86-50A0-47A5-84EA-500FB42DDE2BQ42012573-8DFD333F-C9D5-4D9D-A081-F835303798B7Q42727081-79B31053-7817-4718-A895-0510C7BA539DQ42864050-9101F956-3BEC-4398-A9ED-6102BC764EC2Q43974650-D15703BD-3E8F-4BA4-B3B5-1EADC63E0B55Q46128440-912C0E22-6EEF-4BDF-AB15-3AA369B16420Q46540717-4A6C0249-E2AF-4046-8A47-31A3BFEC8C65Q46676766-5154BDD3-0074-42F2-862C-4D662C4042E0Q46854899-D55B2E80-2CC9-4F5D-AFE5-F0F4807577F4Q47989317-24E82DA6-E5CA-4AB7-9FDE-D4F8A6ADBECBQ48350605-ED0B3A03-4766-4A22-BDCC-F37E7C440053Q48471999-5B0EE874-3701-4390-81CE-B697FCEED6F8Q51349293-7AB5C819-0474-4A33-8E53-4EEAB096FEE6Q55457250-9A1D9B19-BD8A-4D47-92CA-A7BF25990B7FQ56964405-0593CA48-D385-4279-87DF-9FD8846E3890Q58568698-78AE7A49-E2BE-4B2C-9BEF-29E111617888Q64276811-B09802B3-82E3-47C0-9500-38F29EDF7FC6Q84092297-A7BC050C-195B-4617-9B3B-30E2BE75AB28Q84530687-EB4EA88E-A537-4DA2-AE2E-306224376A49Q85295597-AE2613FE-367A-4E45-9F1B-18E0BB2B1854Q85395442-60F6348A-0D09-4603-AF8D-EA4AEDEE6279Q86152430-21243BF4-5FF9-4AFD-A6A1-4CCFA5C7211DQ86559761-4CA1AEE9-905B-42B9-9F87-6FE2025D110DQ86948704-D386FFEA-50BE-4636-8DAD-9C1ED2F8FED5Q87453131-6720C694-810B-44B1-AF97-FDAE4B1DAD59Q87575342-D5D61987-D6C8-48B8-826F-548DC16CBD88Q90609471-A02BFBE7-B6F2-40C5-B333-871D098F6A83Q93190118-88758E5A-C096-45AC-AE90-B46BFDE2819A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Alessandra Ammazzalorso
@en
Alessandra Ammazzalorso
@nl
type
label
Alessandra Ammazzalorso
@en
Alessandra Ammazzalorso
@nl
prefLabel
Alessandra Ammazzalorso
@en
Alessandra Ammazzalorso
@nl
P31
P496
0000-0003-4369-1772